import { Lesson } from '../types/learning';

export const optimizedLesson43: Lesson = {
  id: 'lesson-5-5-optimized',
  moduleId: 'module-5',
  title: "Intraventricular Conduction Delays",
  description: "Master intraventricular conduction delays comprehensively through 6 focused learning units with enhanced interactive elements: IVCD fundamentals and classification, pathophysiology with audio, advanced ECG pattern recognition, clinical significance with audio, management approaches, and expert mastery with celebration audio",
  order: 5,
  estimatedTime: 45,
  content: {
    type: 'mixed',
    introduction: "üéØ Welcome to Intraventricular Conduction Delays Mastery! Master IVCD comprehensively through 6 progressive units with enhanced interactive elements, strategic audio, and real ECG integration from our extensive clinical database.",
    sections: [
      {
        id: 'section-overview',
        title: "üéØ Your IVCD Learning Journey",
        content: "UNIT 1: IVCD Fundamentals & Classification ‚Üí UNIT 2: Pathophysiology + Audio ‚Üí UNIT 3: Advanced ECG Pattern Recognition ‚Üí UNIT 4: Clinical Significance + Audio ‚Üí UNIT 5: Management Approaches ‚Üí UNIT 6: Expert Mastery + Celebration Audio",
        mediaType: 'image'
      }
    ],
    slides: [
      
      // ===============================================
      // üéØ UNIT 1: IVCD FUNDAMENTALS & CLASSIFICATION (7 slides)
      // ===============================================
      {
        id: 'unit1-intro',
        title: 'üéØ Unit 1: IVCD Fundamentals & Classification',
        content: 'Master intraventricular conduction delay fundamentals! Understand the spectrum of IVCD patterns and their significance.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/ecg/medical_accurate/rbbb_70bpm_1.png',
        hint: '‚ö° Master IVCD foundations!'
      },
      
      {
        id: 'ivcd-definition-flashcard',
        title: 'üß† IVCD Definition and Scope',
        content: 'Understanding intraventricular conduction delays',
        type: 'flashcard',
        layout: 'split',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        flashcard: {
          icon: 'üîÑ',
          question: 'What constitutes an intraventricular conduction delay (IVCD)?',
          answer: 'IVCD: ANY abnormal delay in ventricular depolarization. QRS DURATION: ‚â•120ms (some sources ‚â•110ms). PATTERNS: May be specific (LBBB, RBBB) or nonspecific. MECHANISM: Delayed conduction through ventricular myocardium or specialized conduction system.',
          imageUrl: '/lessonimages/module5/lesson43/ivcd-definition.jpg'
        },
        hint: 'üß† Flip to understand IVCD scope!'
      },

      {
        id: 'ivcd-classification-tabs',
        title: 'IVCD Classification System',
        content: 'Systematic approach to IVCD categorization',
        type: 'tabs',
        layout: 'full',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        tabs: [
          {
            title: 'Specific IVCD',
            content: 'Complete LBBB or RBBB patterns. Meets all morphologic criteria. Clear bundle branch involvement. Predictable activation sequence.',
            icon: 'üéØ'
          },
          {
            title: 'Nonspecific IVCD',
            content: 'Wide QRS without LBBB/RBBB criteria. Various morphology patterns. Multiple conduction abnormalities. Less predictable activation.',
            icon: '‚ùì'
          },
          {
            title: 'Incomplete IVCD',
            content: 'QRS 100-119ms duration. Some morphology features present. Partial conduction delay. May progress to complete block.',
            icon: 'üî∂'
          }
        ],
        hint: 'üìë Systematic IVCD classification!'
      },

      {
        id: 'complete-vs-incomplete-steps',
        title: 'Complete vs Incomplete IVCD',
        content: 'Distinguishing complete from incomplete patterns',
        type: 'steps',
        layout: 'full',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'slide',
        steps: [
          {
            number: 1,
            title: 'Complete IVCD (‚â•120ms)',
            description: 'Meets all duration criteria. Full morphologic pattern present. Complete conduction block.'
          },
          {
            number: 2,
            title: 'Incomplete IVCD (100-119ms)',
            description: 'Partial duration prolongation. Some morphologic features. Incomplete conduction delay.'
          },
          {
            number: 3,
            title: 'Clinical Significance',
            description: 'Complete IVCD more clinically significant. Incomplete may progress over time. Both require evaluation.'
          },
          {
            number: 4,
            title: 'Management Implications',
            description: 'Complete IVCD affects CRT eligibility. Incomplete usually observation. Monitor for progression.'
          }
        ],
        hint: 'üë£ Duration determines classification!'
      },

      {
        id: 'nonspecific-ivcd-characteristics',
        title: 'Nonspecific IVCD Characteristics',
        content: 'DEFINITION: Wide QRS not meeting LBBB/RBBB criteria. MORPHOLOGY: Variable patterns across leads. PREVALENCE: ~30% of wide QRS complexes. SIGNIFICANCE: Often indicates extensive myocardial disease or multiple conduction abnormalities.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fdf2f8',
        textColor: '#9d174d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/nonspecific-ivcd.jpg',
        hint: 'üîç Variable patterns, important implications!'
      },

      {
        id: 'ivcd-mechanisms-accordion',
        title: 'IVCD Development Mechanisms',
        content: 'Understanding how IVCD develops',
        type: 'accordion',
        layout: 'full',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        accordionItems: [
          {
            title: 'Bundle Branch Disease',
            content: 'Fibrosis of conduction system. Age-related degeneration. Ischemic damage. Primary electrical disease.',
            icon: 'üå≤'
          },
          {
            title: 'Myocardial Disease',
            content: 'Cardiomyopathy with conduction effects. Myocardial scarring from infarction. Infiltrative diseases. Inflammatory conditions.',
            icon: 'üíî'
          },
          {
            title: 'Metabolic Causes',
            content: 'Electrolyte abnormalities. Drug effects. Toxins. Hypothermia. Usually reversible.',
            icon: '‚öóÔ∏è'
          },
          {
            title: 'Congenital Causes',
            content: 'Congenital heart disease. Inherited conduction disorders. Developmental abnormalities. Present from birth.',
            icon: 'üß¨'
          }
        ],
        hint: 'üéØ Click to explore mechanisms!'
      },

      {
        id: 'ivcd-prevalence-demographics',
        title: 'IVCD Prevalence and Demographics',
        content: 'POPULATION PREVALENCE: 0.5-2% in general population. AGE RELATIONSHIP: Increases significantly with age. GENDER: Slightly more common in males. DISEASE ASSOCIATION: Strong correlation with structural heart disease.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/prevalence-demographics.jpg',
        hint: 'üìä Age and disease strongly linked!'
      },

      {
        id: 'unit1-quiz',
        title: 'Unit 1 Quiz: IVCD Fundamentals',
        content: 'Test your IVCD classification knowledge!',
        type: 'quiz',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        question: 'Nonspecific intraventricular conduction delay is characterized by:',
        options: [
          'QRS duration <100ms with normal morphology',
          'QRS duration ‚â•120ms not meeting LBBB or RBBB criteria',
          'QRS duration 100-119ms with RBBB pattern',
          'Normal QRS duration with axis deviation'
        ],
        correctAnswer: 1,
        explanation: 'Correct! Nonspecific IVCD is defined as QRS duration ‚â•120ms that does not meet the specific morphologic criteria for complete LBBB or RBBB patterns.',
        imageUrl: '/lessonimages/module5/lesson43/unit1-quiz.jpg',
        hint: 'üéØ Think about wide QRS without specific pattern!'
      },

      // ===============================================
      // üéØ UNIT 2: PATHOPHYSIOLOGY + AUDIO (8 slides)
      // ===============================================
      {
        id: 'unit2-intro',
        title: 'üéØ Unit 2: IVCD Pathophysiology + Audio',
        content: 'Discover IVCD pathophysiology! Master the electrical and mechanical consequences of intraventricular conduction delays.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/pathophysiology-overview.jpg',
        hint: '‚öôÔ∏è Understand IVCD mechanisms!'
      },

      {
        id: 'ivcd-pathophysiology-audio',
        title: 'üéß IVCD Pathophysiology Explained',
        content: 'Listen to detailed explanation of intraventricular conduction delay mechanisms',
        type: 'audio',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'slide',
        audioUrl: '/lessonaudio/module5/lesson43/ivcd-pathophysiology.mp3',
        hint: 'üéß Audio guide to IVCD mechanisms!'
      },

      {
        id: 'electrical-consequences-steps',
        title: 'Electrical Consequences of IVCD',
        content: 'Understanding electrical effects of conduction delays',
        type: 'steps',
        layout: 'full',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'slide',
        steps: [
          {
            number: 1,
            title: 'Prolonged Depolarization',
            description: 'QRS duration ‚â•120ms indicates delayed ventricular activation'
          },
          {
            number: 2,
            title: 'Altered Activation Sequence',
            description: 'Abnormal spread of electrical impulse through ventricles'
          },
          {
            number: 3,
            title: 'QRS Morphology Changes',
            description: 'Various patterns depending on location and extent of delay'
          },
          {
            number: 4,
            title: 'Repolarization Abnormalities',
            description: 'Secondary ST-T changes following altered depolarization'
          }
        ],
        hint: 'üë£ Electrical cascade of IVCD!'
      },

      {
        id: 'mechanical-consequences-accordion',
        title: 'Mechanical Consequences of IVCD',
        content: 'Understanding hemodynamic effects',
        type: 'accordion',
        layout: 'full',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'fade',
        accordionItems: [
          {
            title: 'Ventricular Dyssynchrony',
            content: 'Uncoordinated ventricular contraction. Reduced ejection efficiency. Wasted mechanical energy. Primary cause of hemodynamic compromise.',
            icon: 'üíî'
          },
          {
            title: 'Reduced Stroke Volume',
            content: 'Decreased cardiac output. Impaired ventricular filling. Reduced ejection fraction. Particularly problematic with underlying heart disease.',
            icon: 'üìâ'
          },
          {
            title: 'Mitral Regurgitation',
            content: 'Papillary muscle dysfunction. Altered ventricular geometry. Functional MR development. Worsens hemodynamic status.',
            icon: 'üåä'
          },
          {
            title: 'Heart Failure Progression',
            content: 'Accelerated HF development. Worsened symptoms. Increased hospitalization risk. Target for cardiac resynchronization.',
            icon: 'üö®'
          }
        ],
        hint: 'üéØ Click for mechanical effects!'
      },

      {
        id: 'dyssynchrony-types-flashcard',
        title: 'üß† Types of Cardiac Dyssynchrony',
        content: 'Understanding different dyssynchrony patterns',
        type: 'flashcard',
        layout: 'split',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        flashcard: {
          icon: 'üîÑ',
          question: 'What are the main types of cardiac dyssynchrony in IVCD?',
          answer: 'INTERVENTRICULAR: Delay between RV and LV activation. INTRAVENTRICULAR: Delay within same ventricle (LV most important). AV DYSSYNCHRONY: Timing mismatch between atria and ventricles. COMBINATIONS: Multiple types often coexist.',
          imageUrl: '/lessonimages/module5/lesson43/dyssynchrony-types.jpg'
        },
        hint: 'üß† Flip to understand dyssynchrony!'
      },

      {
        id: 'myocardial-consequences',
        title: 'Myocardial Consequences of Prolonged IVCD',
        content: 'STRUCTURAL REMODELING: Ventricular dilatation and hypertrophy. CELLULAR CHANGES: Altered calcium handling, metabolic stress. FUNCTIONAL DECLINE: Progressive heart failure development. ARRHYTHMOGENIC EFFECTS: Increased ventricular arrhythmia risk.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fdf2f8',
        textColor: '#9d174d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/myocardial-consequences.jpg',
        hint: 'ü´Ä Long-term myocardial effects!'
      },

      {
        id: 'crt-mechanism',
        title: 'Cardiac Resynchronization Therapy Mechanism',
        content: 'CRT PRINCIPLE: Restores synchronized ventricular contraction. BIVENTRICULAR PACING: Stimulates both ventricles simultaneously. HEMODYNAMIC IMPROVEMENT: Increased stroke volume and cardiac output. REVERSE REMODELING: Potential for structural recovery.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/crt-mechanism.jpg',
        hint: '‚ö° CRT reverses dyssynchrony!'
      },

      {
        id: 'metabolic-electrical-coupling',
        title: 'Metabolic-Electrical Coupling in IVCD',
        content: 'ENERGY INEFFICIENCY: Dyssynchronous contraction wastes energy. METABOLIC STRESS: Increased oxygen consumption. CALCIUM HANDLING: Altered excitation-contraction coupling. OXIDATIVE STRESS: Free radical generation increases.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/metabolic-coupling.jpg',
        hint: 'üîã Energy waste in dyssynchrony!'
      },

      {
        id: 'unit2-quiz',
        title: 'Unit 2 Quiz: IVCD Pathophysiology',
        content: 'Test your understanding of IVCD mechanisms!',
        type: 'quiz',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        question: 'The primary hemodynamic consequence of IVCD is:',
        options: [
          'Increased blood pressure',
          'Ventricular dyssynchrony leading to reduced cardiac output',
          'Enhanced ventricular filling',
          'Improved exercise tolerance'
        ],
        correctAnswer: 1,
        explanation: 'Correct! The primary hemodynamic consequence of IVCD is ventricular dyssynchrony, which leads to uncoordinated contraction and reduced cardiac output efficiency.',
        imageUrl: '/lessonimages/module5/lesson43/unit2-quiz.jpg',
        hint: 'üéØ Think about coordination loss!'
      },

      // ===============================================
      // üéØ UNIT 3: ADVANCED ECG PATTERN RECOGNITION (7 slides)  
      // ===============================================
      {
        id: 'unit3-intro',
        title: 'üéØ Unit 3: Advanced ECG Pattern Recognition',
        content: 'Master advanced IVCD ECG interpretation! Learn sophisticated pattern recognition for all IVCD types.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/ecg/medical_accurate/lbbb_90bpm_4.png',
        hint: 'üìà Master advanced IVCD patterns!'
      },

      {
        id: 'nonspecific-ivcd-criteria-tabs',
        title: 'Nonspecific IVCD Recognition Criteria',
        content: 'Systematic approach to nonspecific IVCD patterns',
        type: 'tabs',
        layout: 'full',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        tabs: [
          {
            title: 'Duration Criteria',
            content: 'QRS duration ‚â•120ms (some use ‚â•110ms). Does not meet LBBB/RBBB criteria. Variable morphology patterns.',
            icon: '‚è±Ô∏è'
          },
          {
            title: 'Morphology Features',
            content: 'Notched or slurred QRS. Multiple deflections. Variable R-wave progression. Lacks classic bundle patterns.',
            icon: 'üìä'
          },
          {
            title: 'Lead-Specific Patterns',
            content: 'V1-V3: Variable patterns. V4-V6: Broad or notched R waves. Limb leads: Variable morphology.',
            icon: 'üîç'
          }
        ],
        hint: 'üìë Nonspecific but significant patterns!'
      },

      {
        id: 'ivcd-morphology-variants-accordion',
        title: 'IVCD Morphology Variants',
        content: 'Understanding different IVCD patterns',
        type: 'accordion',
        layout: 'full',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'fade',
        accordionItems: [
          {
            title: 'Predominantly Negative IVCD',
            content: 'QS or rS pattern in multiple leads. Often indicates extensive myocardial damage. May resemble old MI pattern. Poor prognosis implications.',
            icon: 'üìâ'
          },
          {
            title: 'Predominantly Positive IVCD',
            content: 'Broad R waves in lateral leads. May have notching or slurring. Better preserved ventricular function. Often hypertensive heart disease.',
            icon: 'üìà'
          },
          {
            title: 'Mixed Pattern IVCD',
            content: 'Variable morphology across leads. Complex conduction abnormalities. Multiple areas of delay. Often extensive disease.',
            icon: 'üîÄ'
          },
          {
            title: 'Intermittent IVCD',
            content: 'Rate-dependent patterns. May be exercise-induced. Progressive conduction disease. Monitor for deterioration.',
            icon: 'üîÑ'
          }
        ],
        hint: 'üéØ Click for pattern variants!'
      },

      {
        id: 'qrs-duration-significance-flashcard',
        title: 'üß† QRS Duration Clinical Significance',
        content: 'Understanding QRS width implications',
        type: 'flashcard',
        layout: 'split',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        flashcard: {
          icon: 'üìè',
          question: 'How does QRS duration correlate with clinical significance in IVCD?',
          answer: 'QRS <120ms: Usually minimal significance. QRS 120-150ms: Moderate dyssynchrony, monitor closely. QRS >150ms: Significant dyssynchrony, CRT candidate if heart failure. QRS >180ms: Severe dyssynchrony, high mortality risk.',
          imageUrl: '/lessonimages/module5/lesson43/qrs-significance.jpg'
        },
        hint: 'üß† Flip for duration significance!'
      },

      {
        id: 'lead-specific-analysis-steps',
        title: 'Lead-Specific IVCD Analysis',
        content: 'Systematic approach to IVCD assessment',
        type: 'steps',
        layout: 'full',
        backgroundColor: '#fdf2f8',
        textColor: '#9d174d',
        animation: 'slide',
        steps: [
          {
            number: 1,
            title: 'Precordial Lead Assessment',
            description: 'V1-V3: Look for R-wave progression abnormalities and notching patterns'
          },
          {
            number: 2,
            title: 'Lateral Lead Evaluation',
            description: 'V4-V6: Assess for broad R waves, notching, and fragmentation'
          },
          {
            number: 3,
            title: 'Limb Lead Analysis',
            description: 'I, aVL, II, III, aVF: Evaluate axis and morphology patterns'
          },
          {
            number: 4,
            title: 'Overall Pattern Integration',
            description: 'Synthesize findings to classify as specific vs nonspecific IVCD'
          }
        ],
        hint: 'üë£ Systematic lead analysis!'
      },

      {
        id: 'fragmented-qrs-significance',
        title: 'Fragmented QRS in IVCD',
        content: 'DEFINITION: Additional R waves or notching in 2+ contiguous leads. MECHANISM: Heterogeneous ventricular activation. SIGNIFICANCE: Indicates myocardial scarring. PROGNOSIS: Associated with increased arrhythmia risk and mortality.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/fragmented-qrs.jpg',
        hint: '‚ö° Fragmentation indicates scarring!'
      },

      {
        id: 'differential-diagnosis-approach',
        title: 'IVCD Differential Diagnosis Approach',
        content: 'EXCLUDE SPECIFIC PATTERNS: Rule out classic LBBB/RBBB first. CONSIDER MIMICS: Ventricular pacing, hyperkalemia, drugs. ASSESS UNDERLYING DISEASE: Look for structural heart disease. REVIEW PREVIOUS ECGs: Determine if new or chronic.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/differential-approach.jpg',
        hint: 'üîç Systematic differential approach!'
      },

      {
        id: 'unit3-quiz',
        title: 'Unit 3 Quiz: Pattern Recognition',
        content: 'Test your IVCD pattern recognition skills!',
        type: 'quiz',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        question: 'Fragmented QRS complexes in IVCD typically indicate:',
        options: [
          'Normal ventricular conduction',
          'Myocardial scarring and heterogeneous activation',
          'Improved cardiac function',
          'Electrolyte imbalance only'
        ],
        correctAnswer: 1,
        explanation: 'Correct! Fragmented QRS complexes in IVCD indicate myocardial scarring and heterogeneous ventricular activation, associated with increased arrhythmia risk.',
        imageUrl: '/lessonimages/module5/lesson43/unit3-quiz.jpg',
        hint: 'üéØ Think about scarring and heterogeneity!'
      },

      // ===============================================
      // üéØ UNIT 4: CLINICAL SIGNIFICANCE + AUDIO (7 slides)
      // ===============================================
      {
        id: 'unit4-intro',
        title: 'üéØ Unit 4: Clinical Significance + Audio',
        content: 'Master IVCD clinical significance! Learn when IVCD patterns have important clinical implications.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/clinical-significance.jpg',
        hint: 'üë©‚Äç‚öïÔ∏è Understand clinical impact!'
      },

      {
        id: 'clinical-significance-audio',
        title: 'üéß Clinical Significance Analysis',
        content: 'Listen to detailed explanation of IVCD clinical significance',
        type: 'audio',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'slide',
        audioUrl: '/lessonaudio/module5/lesson43/clinical-significance.mp3',
        hint: 'üéß Audio guide to clinical relevance!'
      },

      {
        id: 'prognostic-implications-accordion',
        title: 'IVCD Prognostic Implications',
        content: 'Understanding IVCD prognosis by type',
        type: 'accordion',
        layout: 'full',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        accordionItems: [
          {
            title: 'Nonspecific IVCD Prognosis',
            content: 'Generally worse prognosis than specific LBBB/RBBB. Higher all-cause mortality. Increased heart failure risk. Less responsive to CRT.',
            icon: 'üìä'
          },
          {
            title: 'QRS Duration Impact',
            content: 'QRS >120ms: Increased mortality risk. QRS >150ms: Significant CRT benefit potential. QRS >180ms: Very high mortality risk.',
            icon: '‚è±Ô∏è'
          },
          {
            title: 'Heart Failure Correlation',
            content: 'Strong predictor of HF development. Correlates with reduced EF. Independent mortality predictor. CRT consideration important.',
            icon: 'üíî'
          },
          {
            title: 'Arrhythmia Risk',
            content: 'Increased ventricular arrhythmia risk. Higher sudden cardiac death rate. ICD consideration in appropriate candidates.',
            icon: '‚ö°'
          }
        ],
        hint: 'üéØ Click for prognostic details!'
      },

      {
        id: 'heart-failure-relationship-tabs',
        title: 'IVCD and Heart Failure Relationship',
        content: 'Understanding IVCD-HF interactions',
        type: 'tabs',
        layout: 'full',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'fade',
        tabs: [
          {
            title: 'Causal Relationship',
            content: 'IVCD can CAUSE heart failure through dyssynchrony. Mechanical inefficiency leads to progressive dysfunction.',
            icon: '‚û°Ô∏è'
          },
          {
            title: 'Consequence of Disease',
            content: 'Heart failure can CAUSE IVCD through conduction system damage. Progressive cardiomyopathy affects conduction.',
            icon: '‚¨ÖÔ∏è'
          },
          {
            title: 'Bidirectional Effects',
            content: 'Often both cause and consequence. Creates vicious cycle of worsening. Early intervention important.',
            icon: 'üîÑ'
          }
        ],
        hint: 'üìë Complex bidirectional relationship!'
      },

      {
        id: 'crt-eligibility-flashcard',
        title: 'üß† CRT Eligibility in IVCD',
        content: 'Understanding CRT candidacy',
        type: 'flashcard',
        layout: 'split',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        flashcard: {
          icon: '‚ö°',
          question: 'What are the key CRT eligibility criteria for IVCD patients?',
          answer: 'HEART FAILURE: NYHA Class II-IV despite optimal medical therapy. EJECTION FRACTION: ‚â§35%. QRS DURATION: ‚â•120ms (‚â•150ms preferred). LBBB MORPHOLOGY: Strongest indication. NONSPECIFIC IVCD: Weaker indication but still beneficial.',
          imageUrl: '/lessonimages/module5/lesson43/crt-eligibility.jpg'
        },
        hint: 'üß† Flip for CRT criteria!'
      },

      {
        id: 'mortality-predictors',
        title: 'IVCD Mortality Predictors',
        content: 'QRS DURATION: Stronger predictor than morphology. HEART FAILURE: Additive mortality risk. FRAGMENTED QRS: Independent risk factor. AGE: Elderly patients higher risk. COMORBIDITIES: Diabetes, CKD increase risk.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fdf2f8',
        textColor: '#9d174d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/mortality-predictors.jpg',
        hint: 'üìà Multiple interacting risk factors!'
      },

      {
        id: 'acute-settings-significance',
        title: 'IVCD in Acute Settings',
        content: 'NEW IVCD: Always concerning, investigate cause. ACUTE MI: May indicate extensive damage. HEART FAILURE: Sign of decompensation. TOXICITY: Drug or electrolyte effects. INFECTION: Myocarditis consideration.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/acute-significance.jpg',
        hint: 'üö® New IVCD requires investigation!'
      },

      {
        id: 'unit4-quiz',
        title: 'Unit 4 Quiz: Clinical Significance',
        content: 'Test your clinical understanding!',
        type: 'quiz',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        question: 'The IVCD pattern associated with the best CRT response is:',
        options: [
          'Nonspecific IVCD with QRS >150ms',
          'LBBB morphology with QRS >150ms',
          'RBBB morphology with QRS >120ms',
          'Any IVCD with fragmented QRS'
        ],
        correctAnswer: 1,
        explanation: 'Correct! LBBB morphology with QRS >150ms has the strongest evidence for CRT benefit, with the best response rates and outcomes.',
        imageUrl: '/lessonimages/module5/lesson43/unit4-quiz.jpg',
        hint: 'üéØ Think about LBBB and wide QRS!'
      },

      // ===============================================
      // üéØ UNIT 5: MANAGEMENT APPROACHES (6 slides)
      // ===============================================
      {
        id: 'unit5-intro',
        title: 'üéØ Unit 5: Management Approaches',
        content: 'Master evidence-based IVCD management! Learn systematic approaches to IVCD patient care.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/management-approaches.jpg',
        hint: '‚öïÔ∏è Evidence-based IVCD management!'
      },

      {
        id: 'ivcd-management-algorithm-steps',
        title: 'IVCD Management Algorithm',
        content: 'Systematic approach to IVCD management',
        type: 'steps',
        layout: 'full',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'slide',
        steps: [
          {
            number: 1,
            title: 'Initial Assessment',
            description: 'Determine if new or chronic IVCD. Assess symptoms and functional status. Evaluate for underlying causes.'
          },
          {
            number: 2,
            title: 'Structural Evaluation',
            description: 'Echocardiogram for function assessment. Look for regional wall motion abnormalities. Assess for dyssynchrony.'
          },
          {
            number: 3,
            title: 'Heart Failure Optimization',
            description: 'Maximize guideline-directed medical therapy. ACE inhibitor, beta-blocker, aldosterone antagonist.'
          },
          {
            number: 4,
            title: 'Device Therapy Consideration',
            description: 'Evaluate CRT eligibility. Consider ICD if indicated. Monitor for progression.'
          }
        ],
        hint: 'üë£ Systematic management approach!'
      },

      {
        id: 'crt-optimization-tabs',
        title: 'CRT Optimization Strategies',
        content: 'Maximizing CRT benefit in IVCD',
        type: 'tabs',
        layout: 'full',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'fade',
        tabs: [
          {
            title: 'Patient Selection',
            content: 'Optimal candidates: LBBB >150ms, NYHA II-IV, EF ‚â§35%. Good candidates: Nonspecific IVCD >150ms with HF.',
            icon: 'üéØ'
          },
          {
            title: 'Lead Placement',
            content: 'Optimal LV lead position crucial. Avoid scarred areas. Target latest activation zone. Echo guidance helpful.',
            icon: 'üìç'
          },
          {
            title: 'Programming',
            content: 'AV delay optimization. VV delay programming. Rate response settings. Regular follow-up and adjustment.',
            icon: '‚öôÔ∏è'
          }
        ],
        hint: 'üìë Optimize CRT outcomes!'
      },

      {
        id: 'medical-therapy-optimization-accordion',
        title: 'Medical Therapy Optimization',
        content: 'Comprehensive medical management',
        type: 'accordion',
        layout: 'full',
        backgroundColor: '#fdf2f8',
        textColor: '#9d174d',
        animation: 'fade',
        accordionItems: [
          {
            title: 'Heart Failure Medications',
            content: 'ACE inhibitor or ARB titrated to maximum tolerated dose. Beta-blocker (carvedilol, metoprolol, bisoprolol). Aldosterone antagonist if indicated.',
            icon: 'üíä'
          },
          {
            title: 'Newer Therapies',
            content: 'SGLT2 inhibitors (dapagliflozin, empagliflozin). ARNI (sacubitril/valsartan) if appropriate. Ivabradine for heart rate >70.',
            icon: 'üÜï'
          },
          {
            title: 'Monitoring Parameters',
            content: 'Renal function and electrolytes. Blood pressure and heart rate. Symptoms and functional status. Device interrogation.',
            icon: 'üìä'
          }
        ],
        hint: 'üéØ Click for medical optimization!'
      },

      {
        id: 'monitoring-surveillance-flashcard',
        title: 'üß† IVCD Monitoring and Surveillance',
        content: 'Long-term IVCD management',
        type: 'flashcard',
        layout: 'split',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        flashcard: {
          icon: 'üëÅÔ∏è',
          question: 'What monitoring is required for IVCD patients?',
          answer: 'REGULAR ECG: Monitor QRS progression. ECHO SURVEILLANCE: Assess function changes. SYMPTOM MONITORING: Watch for HF progression. DEVICE FOLLOW-UP: If CRT/ICD implanted. MEDICATION MONITORING: Titrate heart failure therapy.',
          imageUrl: '/lessonimages/module5/lesson43/monitoring-surveillance.jpg'
        },
        hint: 'üß† Flip for monitoring strategy!'
      },

      {
        id: 'special-populations',
        title: 'IVCD in Special Populations',
        content: 'ELDERLY: Higher comorbidity burden, careful CRT selection. WOMEN: Equal benefit from CRT, under-represented in trials. DIABETES: Higher mortality risk, aggressive management. KIDNEY DISEASE: Medication dosing adjustments needed.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/special-populations.jpg',
        hint: 'üë• Tailored approaches needed!'
      },

      {
        id: 'unit5-quiz',
        title: 'Unit 5 Quiz: Management',
        content: 'Test your management knowledge!',
        type: 'quiz',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        question: 'The first step in managing a patient with new IVCD is:',
        options: [
          'Immediate CRT implantation',
          'Assessment of underlying cause and structural evaluation',
          'High-dose diuretic therapy',
          'Restriction of all physical activity'
        ],
        correctAnswer: 1,
        explanation: 'Correct! The first step in managing new IVCD is assessment of the underlying cause and comprehensive structural evaluation with echocardiography.',
        imageUrl: '/lessonimages/module5/lesson43/unit5-quiz.jpg',
        hint: 'üéØ Think about comprehensive evaluation first!'
      },

      // ===============================================
      // üéØ UNIT 6: EXPERT MASTERY + CELEBRATION AUDIO (7 slides)
      // ===============================================
      {
        id: 'unit6-intro',
        title: 'üéØ Unit 6: Expert IVCD Mastery',
        content: 'Congratulations! Achieve expert-level IVCD mastery with advanced concepts and cutting-edge insights!',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/expert-mastery.jpg',
        hint: 'üèÜ Expert-level IVCD achievement!'
      },

      {
        id: 'expert-mastery-audio',
        title: 'üéß Expert Mastery Celebration',
        content: 'Celebrate your comprehensive IVCD mastery achievement!',
        type: 'audio',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'slide',
        audioUrl: '/lessonaudio/module5/lesson43/expert-mastery-celebration.mp3',
        hint: 'üéß Expert achievement celebration!'
      },

      {
        id: 'advanced-ivcd-concepts-accordion',
        title: 'Advanced IVCD Concepts',
        content: 'Cutting-edge IVCD understanding',
        type: 'accordion',
        layout: 'full',
        backgroundColor: '#f0fdf4',
        textColor: '#15803d',
        animation: 'fade',
        accordionItems: [
          {
            title: 'QRS Fragmentation Significance',
            content: 'Reflects myocardial scarring. Predicts arrhythmia risk. Independent mortality predictor. Guide ICD therapy decisions.',
            icon: '‚ö°'
          },
          {
            title: 'Dyssynchrony Assessment',
            content: 'Echo strain imaging. Tissue Doppler parameters. MRI assessment. Predicts CRT response.',
            icon: 'üîç'
          },
          {
            title: 'Genetic Considerations',
            content: 'Familial IVCD patterns. Laminopathies. SCN5A mutations. Genetic counseling considerations.',
            icon: 'üß¨'
          },
          {
            title: 'Emerging Therapies',
            content: 'Conduction system pacing. Leadless CRT. Multipoint pacing. Gene therapy research.',
            icon: 'üöÄ'
          }
        ],
        hint: 'üéØ Click for cutting-edge concepts!'
      },

      {
        id: 'expert-clinical-scenarios-tabs',
        title: 'Expert Clinical Scenarios',
        content: 'Complex IVCD management scenarios',
        type: 'tabs',
        layout: 'full',
        backgroundColor: '#fffbeb',
        textColor: '#92400e',
        animation: 'fade',
        tabs: [
          {
            title: 'CRT Non-Response',
            content: 'Optimize medical therapy first. Check lead position. Consider LV lead revision. Evaluate for other causes.',
            icon: 'üîÑ'
          },
          {
            title: 'IVCD Progression',
            content: 'Monitor QRS widening. Assess functional status. Consider device upgrade. Rule out reversible causes.',
            icon: 'üìà'
          },
          {
            title: 'Acute IVCD Development',
            content: 'Urgent evaluation needed. Rule out MI, toxicity. Consider temporary pacing. Identify reversible causes.',
            icon: 'üö®'
          }
        ],
        hint: 'üìë Complex management scenarios!'
      },

      {
        id: 'future-directions-flashcard',
        title: 'üß† Future Directions in IVCD',
        content: 'Emerging trends and technologies',
        type: 'flashcard',
        layout: 'split',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        flashcard: {
          icon: 'üîÆ',
          question: 'What are the most promising future directions in IVCD management?',
          answer: 'CONDUCTION SYSTEM PACING: His-bundle and LBBB area pacing. AI-ENHANCED ECG: Better prediction algorithms. PRECISION MEDICINE: Genetic-guided therapy. REGENERATIVE THERAPY: Stem cell and gene therapy approaches. REMOTE MONITORING: Continuous rhythm and function assessment.',
          imageUrl: '/lessonimages/module5/lesson43/future-directions.jpg'
        },
        hint: 'üß† Flip for future innovations!'
      },

      {
        id: 'expert-clinical-pearls',
        title: 'üíé Expert IVCD Pearls',
        content: 'PEARL 1: Nonspecific IVCD often indicates more extensive disease than specific patterns. PEARL 2: QRS duration >150ms is key threshold for CRT benefit. PEARL 3: Fragmented QRS predicts arrhythmia risk independently. PEARL 4: New IVCD always requires investigation. PEARL 5: CRT benefit extends beyond heart failure to mortality reduction.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fdf2f8',
        textColor: '#9d174d',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/expert-pearls.jpg',
        hint: 'üíé Professional wisdom collection!'
      },

      {
        id: 'research-frontiers',
        title: 'IVCD Research Frontiers',
        content: 'ARTIFICIAL INTELLIGENCE: ECG interpretation and risk prediction. MULTIMODAL IMAGING: Advanced dyssynchrony assessment. BIOMARKERS: Novel markers for risk stratification. PRECISION THERAPY: Individualized treatment approaches.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/research-frontiers.jpg',
        hint: 'üî¨ Cutting-edge research directions!'
      },

      {
        id: 'mastery-achievement-summary',
        title: 'üèÜ IVCD Mastery Achievement',
        content: 'CLASSIFICATION MASTERY: Complete understanding of IVCD types and variants. PATHOPHYSIOLOGY: Expert knowledge of dyssynchrony mechanisms. ECG MASTERY: Advanced pattern recognition across all morphologies. CLINICAL EXPERTISE: Evidence-based management and risk stratification. FUTURE READY: Understanding of emerging technologies and approaches.',
        type: 'highlight',
        layout: 'centered',
        backgroundColor: '#fef7ff',
        textColor: '#7c2d12',
        animation: 'fade',
        imageUrl: '/lessonimages/module5/lesson43/mastery-achievement.jpg',
        hint: 'üèÜ Complete IVCD mastery achieved!'
      },

      {
        id: 'unit6-final-quiz',
        title: 'Unit 6 Quiz: Expert Validation',
        content: 'Validate your expert IVCD knowledge!',
        type: 'quiz',
        layout: 'centered',
        backgroundColor: '#f0f9ff',
        textColor: '#1e40af',
        animation: 'fade',
        question: 'The IVCD characteristic most strongly predictive of CRT benefit is:',
        options: [
          'QRS fragmentation in multiple leads',
          'LBBB morphology with QRS duration >150ms',
          'Nonspecific IVCD with normal ejection fraction',
          'RBBB pattern with first-degree AV block'
        ],
        correctAnswer: 1,
        explanation: 'Outstanding! LBBB morphology with QRS duration >150ms is the strongest predictor of CRT benefit, with the best evidence for improved outcomes and reverse remodeling.',
        imageUrl: '/lessonimages/module5/lesson43/expert-quiz.jpg',
        hint: 'üéØ Think about optimal CRT response!'
      }
    ],
    summary: "üèÜ Exceptional achievement! You have mastered intraventricular conduction delays comprehensively! You understand IVCD classification, pathophysiology, advanced pattern recognition, clinical significance, evidence-based management, and future directions in IVCD care.",
    keyPoints: [
      "IVCD encompasses specific and nonspecific patterns with QRS duration ‚â•120ms",
      "Nonspecific IVCD often indicates more extensive disease than specific bundle patterns", 
      "Ventricular dyssynchrony is the primary hemodynamic consequence of IVCD",
      "Strategic audio reinforcement in Units 2, 4, and 6 enhanced learning comprehension",
      "QRS duration >150ms is key threshold for optimal CRT benefit, especially with LBBB",
      "Comprehensive evaluation and evidence-based management improve IVCD patient outcomes"
    ],
    resources: [
      {
        title: "IVCD Management Master Class Reference",
        url: "https://ecgkid.com/ivcd-comprehensive-management",
        type: "video"
      }
    ]
  },
  tasks: [
    {
      id: 'expert-ivcd-mastery-assessment',
      type: 'final-assessment',
      xp: 60,
      audio: {
        mainNarration: {
          audioUrl: '/lessonaudio/module5/lesson43/expert-mastery-celebration.mp3',
          duration: 15,
          transcript: 'Remarkable mastery achievement! You have conquered intraventricular conduction delays comprehensively - from classification through cutting-edge management approaches. Your expertise in pattern recognition, dyssynchrony assessment, and evidence-based CRT strategies is now at expert level. This knowledge transforms patient care and outcomes!'
        }
      },
      images: {
        mainImage: '/lessonimages/module5/lesson43/expert-achievement.jpg',
        slideImages: []
      },
      content: {
        prerequisiteMessage: 'üèÜ Expert Assessment: Complete all 6 comprehensive units to unlock this expert-level IVCD mastery evaluation.',
        questions: [
          {
            id: 'ivcd-classification-expert',
            type: 'multiple-choice',
            question: 'Nonspecific intraventricular conduction delay is defined as:',
            options: [
              'QRS duration <120ms with normal morphology',
              'QRS duration ‚â•120ms not meeting LBBB or RBBB morphologic criteria',
              'Any wide QRS complex with bundle branch block pattern',
              'QRS duration 100-119ms with axis deviation'
            ],
            correctAnswer: 1,
            explanation: 'Nonspecific IVCD is defined as QRS duration ‚â•120ms that does not meet the specific morphologic criteria for complete LBBB or RBBB patterns, often indicating complex or extensive conduction abnormalities.',
            imageUrl: '/lessonimages/module5/lesson43/assessment/classification.jpg'
          },
          {
            id: 'dyssynchrony-mechanism-expert',
            type: 'multiple-choice', 
            question: 'The primary hemodynamic consequence of IVCD is:',
            options: [
              'Increased systemic vascular resistance',
              'Ventricular dyssynchrony leading to reduced cardiac efficiency',
              'Enhanced ventricular filling and preload',
              'Improved coronary perfusion pressure'
            ],
            correctAnswer: 1,
            explanation: 'The primary hemodynamic consequence of IVCD is ventricular dyssynchrony, which leads to uncoordinated contraction, reduced mechanical efficiency, and decreased cardiac output.',
            imageUrl: '/lessonimages/module5/lesson43/assessment/dyssynchrony.jpg'
          },
          {
            id: 'crt-optimization-expert',
            type: 'multiple-choice',
            question: 'The IVCD pattern with strongest evidence for CRT benefit is:',
            options: [
              'Nonspecific IVCD with QRS 120-150ms',
              'LBBB morphology with QRS duration >150ms',
              'RBBB pattern with normal ejection fraction',
              'Any IVCD with fragmented QRS complexes'
            ],
            correctAnswer: 1,
            explanation: 'LBBB morphology with QRS duration >150ms has the strongest evidence for CRT benefit, with the best response rates, reverse remodeling, and mortality reduction.',
            imageUrl: '/lessonimages/module5/lesson43/assessment/crt-benefit.jpg'
          },
          {
            id: 'clinical-significance-expert',
            type: 'multiple-choice',
            question: 'Fragmented QRS complexes in IVCD are most significant because they:',
            options: [
              'Indicate normal ventricular conduction patterns',
              'Represent myocardial scarring and predict increased arrhythmia risk',
              'Are always benign findings requiring no follow-up',
              'Only occur in young patients without heart disease'
            ],
            correctAnswer: 1,
            explanation: 'Fragmented QRS complexes in IVCD indicate myocardial scarring and heterogeneous activation, serving as independent predictors of increased arrhythmia risk and mortality.',
            imageUrl: '/lessonimages/module5/lesson43/assessment/fragmentation.jpg'
          }
        ]
      }
    }
  ],
  completed: false,
  attempts: 0,
  createdAt: new Date().toISOString(),
  updatedAt: new Date().toISOString()
};
